[RGLS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -42.99%
YoY- -466.14%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 0 0 0 0 5,000 -
PBT -7,258 -6,718 -7,133 -8,628 -6,033 -6,013 -1,315 213.29%
Tax 83 1 214 1 1 -335 7 422.34%
NP -7,341 -6,719 -7,133 -8,628 -6,034 -6,013 -1,322 214.56%
Tax Rate - - - - - - - -
Total Cost 7,341 6,719 7,133 8,628 6,034 6,013 6,322 10.50%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -26.44 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.50 -0.46 -0.67 -0.99 -0.78 -0.84 -0.28 47.34%
EPS Diluted -0.50 -0.46 -0.67 -0.99 -0.78 -0.84 -0.28 47.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.